Yong-Jiang Li - Search Results

Year	Number of Results
2008	1
2010	2
2011	1
2013	2
2014	1
2015	2
2016	1
2017	11
2018	8
2019	15
2020	8
2021	12
2022	5
2023	4
2024	2

1

Artificial exosomes for translational nanomedicine.

Li YJ, Wu JY, Liu J, Xu W, Qiu X, Huang S, Hu XB, Xiang DX. Li YJ, et al. J Nanobiotechnology. 2021 Aug 12;19(1):242. doi: 10.1186/s12951-021-00986-2. J Nanobiotechnology. 2021. PMID: 34384440 Free PMC article. Review.

2

Nonviral delivery systems for antisense oligonucleotide therapeutics.

Huang S, Hao XY, Li YJ, Wu JY, Xiang DX, Luo S. Huang S, et al. Among authors: li yj. Biomater Res. 2022 Sep 30;26(1):49. doi: 10.1186/s40824-022-00292-4. Biomater Res. 2022. PMID: 36180936 Free PMC article. Review.

3

Recent progress of macrophage vesicle-based drug delivery systems.

Xu WJ, Cai JX, Li YJ, Wu JY, Xiang D. Xu WJ, et al. Among authors: li yj. Drug Deliv Transl Res. 2022 Oct;12(10):2287-2302. doi: 10.1007/s13346-021-01110-5. Epub 2022 Jan 4. Drug Deliv Transl Res. 2022. PMID: 34984664 Review.

4

Apoptotic bodies for advanced drug delivery and therapy.

Zhou M, Li YJ, Tang YC, Hao XY, Xu WJ, Xiang DX, Wu JY. Zhou M, et al. Among authors: li yj. J Control Release. 2022 Nov;351:394-406. doi: 10.1016/j.jconrel.2022.09.045. Epub 2022 Sep 27. J Control Release. 2022. PMID: 36167267 Review.

5

Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.

Li YJ, Wu JY, Wang JM, Xiang DX. Li YJ, et al. J Control Release. 2020 Apr 10;320:105-111. doi: 10.1016/j.jconrel.2020.01.041. Epub 2020 Jan 21. J Control Release. 2020. PMID: 31978441 Review.

6

Emerging strategies for labeling and tracking of extracellular vesicles.

Li YJ, Wu JY, Wang JM, Hu XB, Xiang DX. Li YJ, et al. J Control Release. 2020 Dec 10;328:141-159. doi: 10.1016/j.jconrel.2020.08.056. Epub 2020 Aug 31. J Control Release. 2020. PMID: 32882270 Review.

7

Microfluidic characterization of single-cell biophysical properties and the applications in cancer diagnosis.

Li SS, Xue CD, Li YJ, Chen XM, Zhao Y, Qin KR. Li SS, et al. Among authors: li yj. Electrophoresis. 2023 Nov 1. doi: 10.1002/elps.202300177. Online ahead of print. Electrophoresis. 2023. PMID: 37909658 Review.

8

Antineuroinflammatory therapy: potential treatment for autism spectrum disorder by inhibiting glial activation and restoring synaptic function.

Li YJ, Zhang X, Li YM. Li YJ, et al. CNS Spectr. 2020 Aug;25(4):493-501. doi: 10.1017/S1092852919001603. Epub 2019 Oct 29. CNS Spectr. 2020. PMID: 31659946 Review.

9

Dietary Supplement for Core Symptoms of Autism Spectrum Disorder: Where Are We Now and Where Should We Go?

Li YJ, Ou JJ, Li YM, Xiang DX. Li YJ, et al. Front Psychiatry. 2017 Aug 23;8:155. doi: 10.3389/fpsyt.2017.00155. eCollection 2017. Front Psychiatry. 2017. PMID: 28878697 Free PMC article. Review.

10

Global prevalence of obesity, overweight and underweight in children, adolescents and adults with autism spectrum disorder, attention-deficit hyperactivity disorder: A systematic review and meta-analysis.

Li YJ, Xie XN, Lei X, Li YM, Lei X. Li YJ, et al. Obes Rev. 2020 Dec;21(12):e13123. doi: 10.1111/obr.13123. Epub 2020 Aug 11. Obes Rev. 2020. PMID: 32783349 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year